Colorectal cancer has long baffled scientists because, unlike most tumors, patients often do better when their cancers are ...

For generations, medical students were taught that the map of the human body was essentially complete. Yet cancer imaging has ...

What key experiences or clinical gaps motivated your focus on advancing prostate cancer diagnostics, particularly MRI-led ...

PSA and Ki-67 tumour markers may identify high-risk metastatic castration-sensitive prostate cancer and inform treatment ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...

Miles added that the trial appears to have had a positive impact on his cancer. His initial prostate-specific antigen level – ...

Increasing use of blood tests to detect prostate cancer is leading to overworked doctors. Researchers at the Norwegian ...

Prostate cancer is still one of the most common cancers affecting men, yet new findings indicate that nutrition is significantly involved in its prevention, treatment, and recovery than most patients ...

URO-1, a Greensboro medical device company specialized in prostate and soft tissue cancer diagnostics, is expanding its relationship with Novant Health as a designated vendor for its SUREcore and ...

Francis Medical today announced the first commercial procedure using its Vanquish water vapor ablation system.

Men with prostate cancer who get hormone therapy experience hot flashes, where they experience intense and sudden heat and ...